Outbreak of extensively drug-resistant acinetobacter baumannii indigo-pigmented strains

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3726-3730

  Vilacoba, Elisabet ^a   Almuzara, Marisa ^b   Gulone, Lucia ^a   Rodriguez, Rocio ^a   Pallone, Elida ^a   Bakai, Romina ^a   Centrón, Daniela ^a   Ramírez, María Soledad ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Hospital Interzonal General de Agudos Eva Peronquot   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CRE RECOMBINASE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RNA 16S;

16S RRNA GENE; ABA1 GENE; ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC RESISTANCE; ARGENTINA; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CLONAL SPECIES; CONTROLLED STUDY; EMERGENCY CARE; EPIDEMIC; FEMALE; FLORR GENE; GENE INSERTION SEQUENCE; GENE TRANSFER; GENOMIC ISLAND; HUMAN; INTEGRON; MALE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RPOB GENE; SEQUENCE ANALYSIS; STRA GENE; STRB GENE; SUL2 GENE; TRANSPOSON;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARGENTINA; CLUSTER ANALYSIS; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; INTERSPERSED REPETITIVE SEQUENCES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MOLECULAR TYPING; PIGMENTS, BIOLOGICAL; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 84886487220     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01388-13     Document Type: Article

References (31)

1. Roca I, Espinal P, Vila-Farres X, Vila J. 2012. The Acinetobacter baumannii oxymoron: commensal hospital dweller turned pan-drugresistant menace. Front. Microbiol. 3:148. doi:10.3389/fmicb.2012.00148.
2. Visca P, Seifert H, Towner KJ. 2011. Acinetobacter infection-an emerging threat to human health. IUBMB Life 63:1048-1054.
3. Peleg AY, de Breij A, Adams MD, Cerqueira GM, Mocali S, Galardini M, Nibbering PH, Earl AM, Ward DV, Paterson DL, Seifert H, Dijkshoorn L. 2012. The success of Acinetobacter species; genetic, metabolic and virulence attributes. PLoS One 7:e46984. doi:10.1371/journal.pone .0046984.
4. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21:538-582.
5. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J. Clin. Microbiol. 36:1938-1941.
6. Zarrilli R, Di Popolo A, Bagattini M, Giannouli M, Martino D, Barchitta M, Quattrocchi A, Iula VD, de Luca C, Scarcella A, Triassi M, Agodi A. 2012. Clonal spread and patient risk factors for acquisition of extensively drug-resistant Acinetobacter baumannii in a neonatal intensive care unit in Italy. J. Hosp. Infect. 82:260-265.
7. Chmielarczyk A, Higgins PG, Wojkowska-Mach J, Synowiec E, Zander E, Romaniszyn D, Gosiewski T, Seifert H, Heczko P, Bulanda M. 2012. Control of an outbreak of Acinetobacter baumannii infections using vaporized hydrogen peroxide. J. Hosp. Infect. 81:239-245.
8. Domenech de Celles M, Salomon J, Marinier A, Lawrence C, Gaillard JL, Herrmann JL, Guillemot D. 2012. Identifying more epidemic clones during a hospital outbreak of multidrug-resistant Acinetobacter baumannii. PLoS One 7:e45758. doi:10.1371/journal.pone.0045758.
9. Goic-Barisic I, Towner KJ, Kovacic A, Sisko-Kraljevic K, Tonkic M, Novak A, Punda-Polic V. 2011. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase. J. Hosp. Infect. 77:368-369.
10. Ansaldi F, Canepa P, Bassetti M, Zancolli M, Molinari MP, Talamini A, Ginocchio F, Durando P, Mussap M, Orengo G, Viscoli C, Icardi G. 2011. Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation. J. Hosp. Infect. 79: 134-140.
11. Doukyu N, Toyoda K, Aono R. 2003. Indigo production by Escherichia coli carrying the phenol hydroxylase gene from Acinetobacter sp. strain ST-550 in a water-organic solvent two-phase system. Appl. Microbiol. Biotechnol. 60:720-725.
12. Doukyu N, Nakano T, Okuyama Y, Aono R. 2002. Isolation of an Acinetobacter sp. ST-550 which produces a high level of indigo in a waterorganic solvent two-phase system containing high levels of indole. Appl. Microbiol. Biotechnol. 58:543-546.
13. Lin GH, Chen HP, Huang JH, Liu TT, Lin TK, Wang SJ, Tseng CH, Shu HY. 2012. Identification and characterization of an indigo-producing oxygenase involved in indole 3-acetic acid utilization by Acinetobacter baumannii. Antonie Van Leeuwenhoek 101:881-890.
14. Vaneechoutte M, Dijkshoorn L, Tjernberg I, Elaichouni A, de Vos P, Claeys G, Verschraegen G. 1995. Identification of Acinetobacter genomic species by amplified ribosomal DNA restriction analysis. J. Clin. Microbiol. 33:11-15.
15. Weisburg WG, Barns SM, Pelletier DA, Lane DJ. 1991. 16S ribosomal DNA amplification for phylogenetic study. J. Bacteriol. 173:697-703.
16. CLSI. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA
17. Merkier AK, Catalano M, Ramirez MS, Quiroga C, Orman B, Ratier L, Famiglietti A, Vay C, Di Martino A, Kaufman S, Centron D. 2008. Polyclonal spread of blaOXA-23 and blaOXA-58 in Acinetobacter baumannii isolates from Argentina. J. Infect. Dev. Ctries. 2:235-240.
18. Orman BE, Pineiro SA, Arduino S, Galas M, Melano R, Caffer MI, Sordelli DO, Centron D. 2002. Evolution of multiresistance in nontyphoid Salmonella serovars from 1984 to 1998 in Argentina. Antimicrob. Agents Chemother. 46:3963-3970.
19. Nigro SJ, Post V, Hall RM. 2011. The multiresistant Acinetobacter baumannii European clone I type strain RUH875 (A297) carries a genomic antibiotic resistance island AbaR21, plasmid pRAY and a cluster containing ISAba1-sul2-CR2-strB-strA. J. Antimicrob. Chemother. 66:1928-1930.
20. Ramírez MS, Pineiro S, Centron D. 2010. Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob. Agents Chemother. 54:699-706.
21. Vilacoba E, Almuzara M, Gulone L, Traglia GM, Figueroa SA, Sly G, Fernandez A, Centron D, Ramirez MS. 2013. Emergence and spread of plasmid-borne tet(B)::ISCR2 in minocycline-resistant Acinetobacter baumannii isolates. Antimicrob. Agents Chemother. 57:651-654.
22. Shaikh F, Spence RP, Levi K, Ou HY, Deng Z, Towner KJ, Rajakumar K. 2009. ATPase genes of diverse multidrug-resistant Acinetobacter baumannii isolates frequently harbour integrated DNA. J. Antimicrob. Chemother. 63:260-264.
23. Limansky AS, Viale AM. 2002. Can composition and structural features of oligonucleotides contribute to their wide-scale applicability as random PCR primers in mapping bacterial genome diversity? J. Microbiol. Methods 50:291-297.
24. Yang JY, Brooks S, Meyer JA, Blakesley RR, Zelazny AM, Segre JA, Snitkin ES. 2013. Pan-PCR, a computational method for designing bacterium- typing assays based on whole-genome sequence data. J. Clin. Microbiol. 51:752-758.
25. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL. 2012. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 18: 268-281.
26. Stietz MS, Ramirez MS, Vilacoba E, Merkier AK, Limansky AS, Centron D, Catalano M. 2013. Acinetobacter baumannii extensively drug resistant lineages in Buenos Aires hospitals differ from the international clones I-III. Infect. Genet. Evol. 14:294-301.
27. Grosso F, Carvalho KR, Quinteira S, Ramos A, Carvalho-Assef AP, Asensi MD, Peixe L. 2011. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro? J. Antimicrob. Chemother. 66:62-65.
28. Villalón P, Valdezate S, Medina-Pascual MJ, Rubio V, Vindel A, Saez- Nieto JA. 2011. Clonal diversity of nosocomial epidemic Acinetobacter baumannii strains isolated in Spain. J. Clin. Microbiol. 49:875-882.
29. Ramírez MS, Morales A, Vilacoba E, Marquez C, Centron D. 2012. Class 2 integrons dissemination among multidrug resistance (MDR) clones of Acinetobacter baumannii. Curr. Microbiol. 64:290-293.
30. Ramírez MS, Stietz MS, Vilacoba E, Jeric P, Limansky AS, Catalano M, Centron D. 2011. Increasing frequency of class 1 and 2 integrons in multidrug- resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance. Int. J. Antimicrob. Agents 37:175-177.
31. D'Arezzo S, Capone A, Petrosillo N, Visca P, Ballardini M, Bartolini S, Bordi E, Di Stefano A, Galie M, Minniti R, Meledandri M, Pacciani L, Parisi G, Prignano G, Santini C, Valmarin M, Venditti M, Ziantoni S. 2009. Epidemic multidrug-resistant Acinetobacter baumannii related to European clonal types I and II in Rome (Italy). Clin. Microbiol. Infect. 15:347-357.